Loading...
DD logo

DuPont de Nemours, Inc.NYSE:DD Rapporto sulle azioni

Cap. di mercato US$19.1b
Prezzo delle azioni
US$47.25
US$56.13
15.8% sottovalutato sconto intrinseco
1Y-30.4%
7D-7.6%
Valore del portafoglio
Vista

DuPont de Nemours, Inc.

Report azionario NYSE:DD

Capitalizzazione di mercato: US$19.1b

DuPont de Nemours (DD) Panoramica del titolo

DuPont de Nemours, Inc. fornisce materiali e soluzioni tecnologiche negli Stati Uniti, in Canada, nella regione Asia-Pacifico, in America Latina, in Europa, in Medio Oriente e in Africa. Maggiori dettagli

DD analisi fondamentale
Punteggio fiocco di neve
Valutazione3/6
Crescita futura3/6
Prestazioni passate2/6
Salute finanziaria6/6
Dividendi2/6

DD Community Fair Values

Create Narrative

See what 55 others think this stock is worth. Follow their fair value or set your own to get alerts.

Concorrenti di DuPont de Nemours, Inc.

Storia dei prezzi e prestazioni

Riepilogo dei massimi, dei minimi e delle variazioni dei prezzi delle azioni per DuPont de Nemours
Prezzi storici delle azioni
Prezzo attuale dell'azioneUS$47.25
Massimo di 52 settimaneUS$83.40
Minimo di 52 settimaneUS$33.34
Beta1.06
Variazione di 1 mese0.53%
Variazione a 3 mesi-5.95%
Variazione di 1 anno-30.42%
Variazione a 3 anni-28.70%
Variazione a 5 anni-43.45%
Variazione dall'IPO386.00%

Notizie e aggiornamenti recenti

Aggiornamento della narrazione May 07

DD: PFAS Legal Overhang Will Set Up Future Buyback And Guidance Upside

Analysts have slightly adjusted their 12 month price target for DuPont de Nemours to about $63.81 from $64.00. This reflects updated assumptions for revenue growth, profit margins and future P/E expectations.
Seeking Alpha May 07

DuPont: Margin Momentum Is Real, And The Market Is Starting To Take Notice (Rating Downgrade)

Summary DuPont de Nemours has repositioned its portfolio, driving strong Q1 results and a 28% share rally over six months. Management raised full-year guidance, now expecting $2.35–$2.40 EPS and $7.16–$7.22B sales, citing segment strength and new product launches. Despite robust execution and shareholder returns, DD's forward P/E of ~21x and recent rally leave shares fairly valued with limited near-term upside. I downgrade DD from buy to hold, noting Middle East risks to Water segment and the need to monitor segment performance for downside. Read the full article on Seeking Alpha

Recent updates

Aggiornamento della narrazione May 07

DD: PFAS Legal Overhang Will Set Up Future Buyback And Guidance Upside

Analysts have slightly adjusted their 12 month price target for DuPont de Nemours to about $63.81 from $64.00. This reflects updated assumptions for revenue growth, profit margins and future P/E expectations.
Seeking Alpha May 07

DuPont: Margin Momentum Is Real, And The Market Is Starting To Take Notice (Rating Downgrade)

Summary DuPont de Nemours has repositioned its portfolio, driving strong Q1 results and a 28% share rally over six months. Management raised full-year guidance, now expecting $2.35–$2.40 EPS and $7.16–$7.22B sales, citing segment strength and new product launches. Despite robust execution and shareholder returns, DD's forward P/E of ~21x and recent rally leave shares fairly valued with limited near-term upside. I downgrade DD from buy to hold, noting Middle East risks to Water segment and the need to monitor segment performance for downside. Read the full article on Seeking Alpha
Aggiornamento della narrazione Apr 23

DD: PFAS Legal Overhang Will Set Up Future Water And Healthcare Upside

Analysts reaffirm a $64.00 price target on DuPont de Nemours, citing modest adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions rather than a shift in their overall view of the shares. What's in the News DuPont plans to seek shareholder approval in May 2026 for a potential reverse stock split of its common stock at a ratio between 1 for 2 and 1 for 4, with the board retaining discretion on timing and whether to proceed.
Aggiornamento della narrazione Apr 08

DD: Share Actions And Water Solutions Expansion Will Shape A Measured Outlook

Analysts have adjusted the price target for DuPont de Nemours from $44 to $50, reflecting updated assumptions around revenue growth, profit margins, a revised discount rate, and slightly lower future P/E expectations. What's in the News DuPont plans to seek shareholder approval to amend its certificate of incorporation to allow a reverse stock split of common shares at a ratio between 1-for-2 and 1-for-4, with the exact ratio and timing at the discretion of the board.
Aggiornamento della narrazione Mar 24

DD: PFAS Legal Overhang Will Set Up Future Product Expansion Upside

Analysts have raised their price target on DuPont de Nemours from about $55 to $64, citing updated assumptions for revenue growth, profit margins, and a lower discount rate that together support a reduced future P/E estimate. What's in the News The company plans to seek shareholder approval for a reverse stock split in a range of 1 for 2 to 1 for 4 at the May 21, 2026 annual meeting.
Aggiornamento della narrazione Mar 09

DD: Water Technology Expansion And 2026 Guidance Will Support Future Upside

Analysts have kept their $56.13 price target for DuPont de Nemours unchanged, citing largely steady assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Together, these factors signal a consistent outlook on the stock's risk and return profile.
Aggiornamento della narrazione Feb 23

DD: New Guidance And Product Pipeline Will Support Future Upside

Analysts have raised their price target on DuPont de Nemours from about $49.19 to $56.13, citing updated assumptions for revenue growth, profit margins, discount rate, and future P/E that they view as better reflecting the company’s potential risk and return profile. What's in the News Issued new earnings guidance for the first quarter of 2026, with expected net sales of $1,670 million.
Articolo di analisi Feb 17

There May Be Reason For Hope In DuPont de Nemours' (NYSE:DD) Disappointing Earnings

The market was pleased with the recent earnings report from DuPont de Nemours, Inc. ( NYSE:DD ), despite the profit...
Aggiornamento della narrazione Feb 09

DD: Legal PFAS Overhang Will Set Up Future Product Expansion Upside

Analysts have revised their price target for DuPont de Nemours from about US$113 to roughly US$55, reflecting updated views on fair value, a higher discount rate, softer revenue growth expectations, slightly lower profit margins, and a higher assumed future P/E multiple. What's in the News DuPont launched the FilmTec MXP RO-8038-FF reverse osmosis element for dairy processors, designed as a drop in option for mesh wrapped systems that targets around 5% higher active membrane area and up to 50% higher productivity compared with conventional mesh wrapped elements, while aiming to reduce wastewater and maintain existing plant setups (Product related announcement).
Aggiornamento della narrazione Jan 26

DD: Share Buybacks Will Drive Future Upside As New Plant Expands Capacity

Analysts have raised their price target for DuPont de Nemours from US$47.31 to US$49.19, citing updated assumptions around discount rates, revenue trends, profit margins and a revised future P/E outlook. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit related to alleged PFAS risks in firefighter turnout gear that names DuPont alongside other manufacturers, allowing claims under multiple legal theories, including RICO, to proceed for now (Lawsuits & Legal Issues).
Aggiornamento della narrazione Jan 12

DD: Share Returns And Qnity Separation Will Frame A Measured Forward Outlook

Analysts have maintained their price target for DuPont de Nemours at $44.00, with this reaffirmed view supported by updated assumptions of a smaller revenue decline, higher profit margins, and a lower future P/E multiple. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit alleging DuPont and other manufacturers concealed health risks linked to PFAS chemicals in firefighter turnout gear, allowing RICO and other claims to proceed for now (Lawsuits & Legal Issues).
Aggiornamento della narrazione Dec 27

DD: Share Buybacks Will Drive Future Upside As New China Plant Expands Capacity

Narrative Update on DuPont de Nemours Analysts have modestly raised their average price target on DuPont de Nemours by approximately $0.06, reflecting slightly improved views on the company’s discount rate and profit margin outlook, despite marginally weaker revenue growth expectations. What's in the News Begins construction of a new MOLYKOTE specialty lubricants plant in Zhangjiagang, China, expanding global capacity and targeting fast growing demand across transportation, industrial, energy, and electronics markets, with operations expected to start in early 2027 (Key Developments) The board authorizes a share repurchase program of up to $2 billion, indicating a focus on capital returns to shareholders (Key Developments) Issues updated 2025 guidance, trimming full year net sales expectations to $6.84 billion and guiding fourth quarter net sales of about $1.685 billion (Key Developments) Declares a quarterly dividend of $0.20 per share, payable December 15, 2025, and also approves a pro rata special dividend to spin off Qnity to existing shareholders on November 1, 2025 (Key Developments) Introduces new safety and industrial products, including Tyvek APX high breathability chemical protective garments and IntegraTec XTP 100 IG ultrafiltration modules, together with new comfort and mobility testing protocols for soft ballistic body armor (Key Developments) Valuation Changes Fair Value: risen slightly from $47.25 to about $47.31 per share, indicating a marginally higher intrinsic value estimate.
Aggiornamento della narrazione Dec 13

DD: Share Returns And Qnity Separation Will Shape A Balanced Outlook

Narrative Update Analysts have cut their average 12 month price target on DuPont de Nemours to approximately 44 dollars from about 62 dollars. This reflects reduced expectations for revenue growth and profit margins, along with a higher assumed valuation multiple and discount rate.
Aggiornamento della narrazione Nov 29

DD: Share Repurchase Plan Will Drive Upside as New Plant Breaks Ground

Analysts have revised their price target for DuPont de Nemours downward by $6.00 to $47.25, citing recent adjustments in growth and profitability expectations. What's in the News DuPont broke ground on a new MOLYKOTE specialty lubricants manufacturing plant in Zhangjiagang, China.
Aggiornamento della narrazione Nov 15

DD: Future Share Buybacks Will Unlock Value Amid Uncertainty

Analysts have revised their price target for DuPont de Nemours sharply downward from $93.69 to $53.25, citing updated financial forecasts and increased market uncertainty. What's in the News DuPont unveiled Tyvek APX, a new disposable chemical garment fabric designed for increased comfort and breathability without compromising protection.
Articolo di analisi Nov 09

DuPont de Nemours (NYSE:DD) Is Paying Out Less In Dividends Than Last Year

DuPont de Nemours, Inc. ( NYSE:DD ) is reducing its dividend from last year's comparable payment to $0.20 on the 15th...
Aggiornamento della narrazione Nov 01

DD: Qnity Separation And Water Solutions Will Drive Outperformance

Analysts have slightly reduced their price target for DuPont de Nemours from $93.81 to $93.69. This change reflects modest adjustments in growth forecasts and profitability expectations.
Aggiornamento della narrazione Oct 17

Electronics, Healthcare And Water Will Drive Future Success

Analysts have raised their price target for DuPont de Nemours from $92.67 to $93.81. They cite modest improvements in profit margin expectations and slightly adjusted growth assumptions as the reasons for this change.
Aggiornamento della narrazione Sep 24

Electronics, Healthcare And Water Will Drive Future Success

Despite a reduced revenue growth outlook, improved net profit margins have driven the consensus analyst price target for DuPont de Nemours up from $89.31 to $92.67. What's in the News DuPont is actively pursuing strategic bolt-on acquisitions, focusing on enhancing capabilities and targeting growth opportunities, while maintaining a balanced approach between buybacks and M&A.
Aggiornamento della narrazione Sep 04

Electronics, Healthcare And Water Will Drive Future Success

As DuPont de Nemours’ revenue growth and discount rate forecasts remained steady, analysts kept their price target unchanged at $89.31. What's in the News Analyst/Investor Day announced.
Articolo di analisi Jul 23

Is DuPont de Nemours, Inc. (NYSE:DD) Trading At A 47% Discount?

Key Insights Using the 2 Stage Free Cash Flow to Equity, DuPont de Nemours fair value estimate is US$146 DuPont de...
Seeking Alpha Apr 07

DuPont: Upgrading To Hold Amid China Risks

Summary DuPont shares have underperformed the broader market since my Sell recommendation was published. A new antitrust probe by the Chinese government is a negative but the stock's valuation reflects this risk. I believe it will be difficult for the company to meet consensus EPS estimates given the macroeconomic backdrop. I up upgrading the stock to Hold as a view the risk-reward more balanced for the stock now than was previously the case. Read the full article on Seeking Alpha

Rendimenti per gli azionisti

DDUS ChemicalsUS Mercato
7D-7.6%-3.2%-0.3%
1Y-30.4%7.8%26.7%

Ritorno vs Industria: DD ha avuto una performance inferiore rispetto al US Chemicals che ha registrato un rendimento 7.8 % nell'ultimo anno.

Rendimento vs Mercato: DD ha avuto una performance inferiore al mercato US che ha registrato un rendimento 26.7 % nell'ultimo anno.

Volatilità dei prezzi

Is DD's price volatile compared to industry and market?
DD volatility
DD Average Weekly Movement4.9%
Chemicals Industry Average Movement7.4%
Market Average Movement7.2%
10% most volatile stocks in US Market16.2%
10% least volatile stocks in US Market3.2%

Prezzo delle azioni stabile: DD non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato US.

Volatilità nel tempo: La volatilità settimanale ( 5% ) di DD è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
201515,000Lori Kochwww.dupont.com

DuPont de Nemours, Inc. fornisce materiali e soluzioni tecnologiche negli Stati Uniti, in Canada, nella regione Asia-Pacifico, in America Latina, in Europa, in Medio Oriente e in Africa. Opera attraverso due segmenti, Healthcare & Water Technologies e Diversified Industrials. L'azienda offre componenti speciali per dispositivi medici, imballaggi, indumenti e tute protettive con il marchio TYVEK; fornisce soluzioni per la filtrazione e la separazione dell'acqua, tra cui elementi, moduli e sistemi che servono principalmente i mercati delle acque reflue industriali e dell'energia, le applicazioni municipali e di desalinizzazione, le scienze della vita e i settori speciali.

DuPont de Nemours, Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di DuPont de Nemours con la sua capitalizzazione di mercato?
DD statistiche fondamentali
Capitalizzazione di mercatoUS$19.09b
Utili (TTM)US$132.00m
Ricavi(TTM)US$6.92b
146.7x
Rapporto P/E
2.8x
Rapporto P/S

Utili e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
DD Conto economico (TTM)
RicaviUS$6.92b
Costo del fatturatoUS$4.50b
Profitto lordoUS$2.42b
Altre speseUS$2.29b
UtiliUS$132.00m

Ultimi utili riportati

Mar 31, 2026

Prossima data di guadagno

n/a

Utile per azione (EPS)0.32
Margine lordo35.01%
Margine di profitto netto1.91%
Rapporto debito/patrimonio netto22.6%

Come si è comportato DD nel lungo periodo?

Vedi performance storica e confronto

Dividendi

1.7%
Rendimento attuale del dividendo
384%
Rapporto di remunerazione
Quando è necessario acquistare DD per ricevere un dividendo imminente?
DuPont de Nemours date dei dividendi
Data di stacco del dividendoMay 15 2026
Data di pagamento dei dividendiMay 29 2026
Giorni fino al dividendo Ex7 days
Giorni prima della data di pagamento dei dividendi7 days

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/05/20 12:13
Prezzo dell'azione a fine giornata2026/05/20 00:00
Utili2026/03/31
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

DuPont de Nemours, Inc. è coperta da 38 analisti. 14 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
William SeleskyArgus Research Company
Patrick Duffy FischerBarclays
Michael LeitheadBarclays